ContentsSynopsisCodesDifferential Diagnosis & PitfallsBest TestsDrug Reaction DataReferencesView all Images (2)
Endomyocardial fibrosis
Print
Other Resources UpToDate PubMed

Endomyocardial fibrosis

Print Images (2)
Contributors: Michael W. Winter MD, Ryan Hoefen MD, PhD
Other Resources UpToDate PubMed

Synopsis

Endomyocardial fibrosis (EMF) is a restrictive cardiomyopathy characterized by abnormal fibrous endocardial thickening of either or both ventricles. Associated with high mortality. The origin of the disease is unknown, and cases occur almost exclusively in regions within 15 degrees of the Equator. In these regions, EMF is a common cause of heart failure, with most cases occurring in adolescents and young adults. In temperate climates, Loeffler disease is a nearly identical presentation. Signs and symptoms of EMF include atrioventricular valve regurgitation, enlarged ventricle(s), dyspnea, facial or limb edema, orthopnea, and fatigue. Comorbidities include ascites, pleural / pericardial effusions, and atrial fibrillation / arrhythmia.

Codes

ICD10CM:
I42.3 – Endomyocardial (eosinophilic) disease

SNOMEDCT:
398716006 – Endomyocardial Fibrosis

Differential Diagnosis & Pitfalls

Best Tests

Subscription Required

Drug Reaction Data

Below is a list of drugs with literature evidence indicating an adverse association with this diagnosis. The list is continually updated through ongoing research and new medication approvals. Click on Citations to sort by number of citations or click on Medication to sort the medications alphabetically.

Subscription Required

References

Subscription Required

Last Updated: 06/02/2017
Copyright © 2018 VisualDx®. All rights reserved.
Endomyocardial fibrosis
Print 2 Images
View all Images (2)
(with subscription)
Endomyocardial fibrosis (Left Ventricular) : Fatigue, Exertional dyspnea, EOS increased, Orthopnea
Copyright © 2018 VisualDx®. All rights reserved.